[Abstract] The beneficial effects of mesenchymal stem cell (MSC)-based cellular therapies are believed to be mediated primarily by the ability of MSCs to suppress inflammation associated with chronic or acute injury, infection, autoimmunity, and graft-versus-host disease. To specifically address the effects of frictional force caused by blood flow, or wall shear stress (WSS), on human MSC immunomodulatory function, we have utilized microfluidics to model WSS at the luminal wall of arteries. Anti-inflammatory potency of MSCs was subsequently quantified via measurement of TNF-α production by activated murine splenocytes in co-culture assays. The TNF-α suppression assay serves as a reproducible platform for functional assessment of MSC potency and demonstrates predictive value as a surrogate assay for MSC therapeutic efficacy.
2 to trauma to the central nervous system, pericytes have been shown to migrate away from microvessels concurrent with perivascular edema and toward injured tissue in association with blood vessel sprouting (Dore-Duffy et al., 2000; Göritz et al., 2011) . Cells described as having features of MSCs have been detected circulating in human peripheral blood (Zvaifler et al., 2000) , though there is some controversy surrounding evidence for MSCs in the circulation of healthy and even injured individuals (Hoogduijn et al., 2014) . In those cases, disruption of endothelial-pericyte interactions could be expected to exacerbate vascular hyperpermeability which could impact migration or intravasation of MSCs (Mills et al., 2013) .
As MSCs are anchorage-dependent cells, a likely means of motility would include attachment to the vessel wall resulting in direct exposure to intraluminal WSS. In therapeutic applications wherein MSCs are administered intravenously, WSS would be an unavoidable stimulus during handling, infusion, and trafficking (Nitzsche et al., 2017) .
We have shown that WSS typical of arterial blood flow promotes signaling through focal adhesion kinase (FAK), NF-κB, and COX2 Lee et al., 2017) . Increased COX2 results in elevated prostaglandin E2 (PGE2) biosynthesis. PGE2 secreted by MSCs plays a central role in regulation of innate and adaptive immune cells. Thus, MSCs exposed to WSS more potently suppress immune cell activation in the presence of inflammatory cues Lee et al., 2017) . To quantify MSC immunomodulatory activity in cells exposed to fluid flow, we co-cultured MSCs and lipopolysaccharideactivated murine splenocytes in an adaptation of the commonly used mixed lymphocyte reaction (Plumas et al., 2005) . TNF-α was measured by species specific ELISA to determine cytokine production from activated murine splenocytes, thus restricting analysis to immune cell activity and enabling separate determinations of cytokine production by human MSCs. Employing this assay as a surrogate measure of MSC potency, we determined that transient exposure of MSCs to fluid shear stress improved their ability to limit activation of immune cells in the presence of inflammatory stimulus. Preconditioning of MSCs by as little as 3 h of WSS in culture was an effective means of enhancing therapeutic efficacy in treatment of a rat traumatic brain injury model. These data demonstrate that WSS enhances the immunomodulatory and neuroprotective function of MSCs. Together with complementary studies implicating PGE2 as a potency marker of MSC therapeutic efficacy (Kota et al., 2017) , our studies suggest that mechanotransduction could be leveraged to improve cellular therapies available for patients with neurological injury. This co-culture assay could easily be adapted for analysis of antiinflammatory potency of MSCs subjected to a variety of treatments, including genetically engineered MSCs. 28. Atlanta Biological fetal bovine serum (FBS), embryonic stem cell qualified, 500 ml (Atlanta Biologicals, catalog number: S10250)
Materials and Reagents
29. Red blood cell lysing buffer hybri-max (Sigma-Aldrich, catalog number: R7767-100ML)
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P20-200 XL3000i pipettor (Denville Scientific, catalog number: P3950-200A)
Note: This product has been discontinued.
6. P100-1000 XL3000i pipettor (Denville Scientific, catalog number: P3950-1000A)
Note: This product has been discontinued. 4. Collect the cell suspension by adding 5 ml of MSC media (see Recipes) to curtail the Tryp-LE effects. Add contents into a clean 15 ml conical centrifuge tube.
5. Re-rinse the flask with 2-3 ml of MSC media to collect remnant cells.
6. Add contents into the same 15 ml centrifuge tube.
7. Place the centrifuge tube into a swing bucket tabletop centrifuge (Hettich Rotofix 32A) and spin down suspension at 617 x g (2,000 rpm) for 5 min.
8. Aspirate out the media mix using a vacuum suction, without disturbing the cell pellet.
9. Gently tap with fingers the conical end of the 15 ml centrifuge tube, to aid in pellet disbursal.
Re-suspend the cell pellet with 2 ml of MSC media by gently mixing with a 5 ml serological pipette.
10. Once mixed, quickly take a 10 μl aliquot of cell suspension for cell counting, and place it into a fresh 1.5 ml microcentrifuge tube. Add to the suspension, 10 μl of trypan blue. Mix by pipetting 5-8 times.
11. Take a final 10 μl aliquot of this solution and place into a hemocytometer (Hausser Scientific)
with cover glass (Figure 1 ). 13. Calculate the cell concentration (number of cells per ml) by the sum of 4 quadrant counts multiplied by the dilution factor of 2 and multiplied by the factor 2,500. This will equal cells per ml.
14. Once the cell number per ml is calculated, take the required aliquot of cell suspension needed to obtain a 2 x 10 5 cells per ml.
www.bio-protocol.org/e2513 18. Place the dish inside a 37 °C incubator and allow the cells to attach for 30 min.
19. After 30 min, take the slide out and fill the individual channel by pipet dispensing ~2 drops between each channel reservoir until the full 125 μl of MSC media is dispensed.
Note: This alternating drop-wise dispensing of media for each channel helps to minimize flow disruption, which allows non-attached MSCs to attach uniformly through the channel.
20. Leave the slide overnight at 37 °C.
B. Setting up IBIDI slides for WSS
1. Prior to the WSS, the media must be replenished in each channel of the IBIDI slide. Duplicate channels for each treatment group (static, WSS, and other conditions) are required to obtain sufficient media for analysis in subsequent ELISA assays. Each channel has a reservoir port.
From one end, draw out 125 μl of the old media without drawing out the 30 μl volume in the channel (see Video 1, start to 1:21 min).
www.bio-protocol.org/e2513 3. Using a serological pipet, flush the top of the strainer, using chilled 2% FBS in PBS. Flush at most 10 to 15 ml of buffer. From the bottom of the strainer, using a 1,000 μl pipette tip on pipettor, withdraw any residual suspension of cell-buffer mix and add to the cell suspension.
4. Spin down for 5 min at 640 x g at 4 °C. After centrifugation, note that the supernatant is turbid, but there is a 'red' pellet at the bottom. Pour out the supernatant, without disturbing the pellet.
5. Add 6 ml of RBC lysis buffer and break up the pellet with the buffer using a 5 ml serological pipet. Then let the mixture sit on an ice bath for EXACTLY 7 min of incubation time.
Note: If splenocyte cell mixture is left too long in the RBC lysis buffer, it may affect the cell performance.
6. Setup the 40 μm strainer with a fresh 50 ml conical. To the cell suspension add 20 to 30 ml of 2% FBS in PBS buffer to help quench the RBC lysis buffer. Draw up the suspension using a 10 ml serological pipet and run it through the 40 μm strainer.
7. Change serological pipet and withdraw 10 ml of FBS-PBS buffer. Rinse the original 50 ml conical tube for the RBC lysis then transfer the suspension through the same 40 μm strainer.
8. Again using a 1,000 μl pipet tip, collect any residual cell suspension under the strainer and transfer to the cell suspension. 2. Using a P200 pipettor and tip, remove the media from one end of the slide reservoir, down to the point that only the channel contains media (both reservoirs should be empty). Add 125 μl of fresh media at the opposite end of the slide reservoir, to rinse the channel. Repeat one more time.
www.bio-protocol.org/e2513 6. You will need a splenocyte only culture used as a control for LPS treatment and non-treatment.
Use a fresh IBIDI VI 0.4 slide and fill four channels with 30 μl of splenocytes.
7. Allow to incubate for 30 min with the co-cultured slides.
8. After 30 min, fill the channel reservoirs by gently dispensing 45 μl of MSC media.
9. Prepare a 2x concentration of lipopolysaccharide (LPS) at 2 μg/ml. The stock solution is 1 mg/ml and the final concentration in the channel will be 1 μg/ml.
10. There will be 75 μl of media volume in the slide channels. Add 75 μl of the 2x LPS, alternating ~2 drops between each channel reservoir port until the 75 μl is dispensed for the one channel.
After all channels on the slide are filled, gently pick up the slide with thumb and index finger and carefully rock it up to 10 ten times from reservoir port side to side to allow the media to flow and mix. Do not allow the media to overflow above the reservoir port rim, which causes media loss.
This rocking motion allows for proper mixing of the LPS with the co-cultured cells and duplicate splenocyte only treatment group. The other duplicate splenocyte set remains untreated, with only MSC media. Place the slide cover on top of the slide and place in the humidified chamber.
11. Place in the incubator for up to 18 h.
E. mTNFα ELISA assay 1. The mTNFα ELISA kit (R&D Systems) must be taken out of the refrigerator and allowed to equilibrate to room temperature for at least 30 min. The TNFα control and the TNFα standard should be each reconstituted with 1 ml of double deionized water. The 25x wash buffer should also be thawed.
After incubation of the co-cultured cells and the splenocyte only control conditions (LPS treated
and non-treated), collect the media from duplicate channels, combining together the two channels for each treatment group into individually marked 1.5 ml microcentrifuge tubes. A volume of two duplicate channels will be approximately 300 μl. Place the microcentrifuge tubes on ice.
3. Transfer the tubes into a refrigerated table top centrifuge and spin down at 650 x g for 5 min at
